1986
DOI: 10.1042/bj2360595
|View full text |Cite
|
Sign up to set email alerts
|

Expression of the v-src or v-fps oncogene increases fructose 2,6-bisphosphate in chick-embryo fibroblasts. Novel mechanism for the stimulation of glycolysis by retroviruses

Abstract: The concentration of fructose 2,6-bisphosphate and the activity of 6-phosphofructo-2-kinase are increased after infection of chick-embryo fibroblasts with the Rous sarcoma virus, or with a temperature-sensitive mutant of this virus at the permissive, but not at the non-permissive, temperature. This is observed after transformation by retroviruses carrying either the v-src or v-fps, but not the v-mil and/or v-myc, oncogenes.Comparison of the effects of the Rous sarcoma virus with those of phorbol myristate acet… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
33
0

Year Published

1990
1990
2001
2001

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 51 publications
(34 citation statements)
references
References 23 publications
1
33
0
Order By: Relevance
“…F2,6BP is considered to be the most potent stimulator of glycolysis and acts by allosteric activation of PFK-1, which phosphorylates F6P to produce F1,6BP (3,4). PFK-2 catalyzes the synthesis of F2,6BP from F6P, and, in chick-embryo fibroblasts, this catalytic activity has been shown to be increased by oncogenic retroviral transformation (10). Several tissue-specific isoenzymes of PFK-2 have been described, but the isoenzyme that is associated with the enhanced glycolysis of tumor cells has not been identified previously (4).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…F2,6BP is considered to be the most potent stimulator of glycolysis and acts by allosteric activation of PFK-1, which phosphorylates F6P to produce F1,6BP (3,4). PFK-2 catalyzes the synthesis of F2,6BP from F6P, and, in chick-embryo fibroblasts, this catalytic activity has been shown to be increased by oncogenic retroviral transformation (10). Several tissue-specific isoenzymes of PFK-2 have been described, but the isoenzyme that is associated with the enhanced glycolysis of tumor cells has not been identified previously (4).…”
Section: Discussionmentioning
confidence: 99%
“…Multiple established cancer cell lines (i.e., Ehrlich ascites tumor cells, HeLa cells, HT29 colon adenocarcinoma cells, and Lewis lung carcinoma cells) have markedly elevated levels of F2,6BP when compared with normal tissue cells (6)(7)(8)(9). Transformation of chick-embryo fibroblasts by retroviruses carrying either the v-src or v-fps oncogenes has been observed to induce F2,6BP synthesis and to cause increased glycolytic flux and cell proliferation (10). These data suggest that activation and͞or over-expression of PFK-2-catalyzed F2,6BP synthesis may contribute to transformation and cancer cell proliferation (4,5).…”
mentioning
confidence: 99%
“…There is also, in tumours, a correlation between the high glycolytic flux maintained by these tissues and the activity of the liver isoform of PFK-1 (PFK-L) [3]. Furthermore, the level of fructose 2,6-bisphosphate in tumour cells is often increased, and transformation of cells with retroviruses containing either the v-src or v-fps oncogene has been shown to increase both the fructose 2,6-bisphosphate concentration and glycolytic flux [4,5]. However, although it is clear that the enzyme is tightly regulated and that there is a correlation between its activity and glycolytic flux, the evidence that it is rate-limiting for glycolytic flux is very poor.…”
Section: Introductionmentioning
confidence: 99%
“…Several mechanisms for such energy metabolism have been suggested, e.g. small mitochondria content and their abnormal structure [1,2], elevated ATPases activities [3,4]° high hexo~ kinase activity and its association with mitochondrial outer membrane [5], increased level of frttetose-2,6-diphosphate, a glycolysis activator [6]. However, the contribution of the proposed mechanisms in the bioenergeties of tumor cells has not been fully evaluated.…”
Section: Introductionmentioning
confidence: 99%